Baluarte, Rowegen .

HRN: 24-30-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2023
AMPICILLIN 1GM (VIAL)
12/26/2023
12/27/2023
IV
2gm
Q6
Prom 18hrs
Waiting Final Action 
12/27/2023
CO-AMOXICLAV 625MG (TAB)
12/27/2023
01/03/2024
PO
625mg
BID X 7 Days
PROM X 35 Hour; S/P NSVD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: